Login

Categories

Consumer Corporate Energy Entertainment Experts Financials Healthcare Industrial Law Markets Media Mining Private Equity Real Estates Sports Startups Technology Venture Capital

Recent Videos

00:00:00
The vast global opportunity for the Maxigesic painkiller - Dr Hartley Atkinson Chief Executive Officer, Executive Director and Co-Founder, AFT Pharmaceuticals Ltd
00:00:00
Medical device, used in patients undergoing breast reconstruction following a mastectomy - Scott Dodson, CEO, AirXpanders Inc.
00:00:00
Taking the opportunity to give an update to the Company's shareholders - Søren Bregenholt CEO, Alligator Bioscience
00:00:00
Inflammation & Antibodies with Ampio Pharmaceutical - Michael A. Martino, Chief Executive Officer, Ampio Pharmaceuticals Inc
00:00:00
Company's successful listing on the exchange - Joe Wiley, CEO of Amryt Pharma
00:00:00
Christopher U. Missling, PhD, President & CEO of Anavex Life Sciences Corp.
00:00:00
Discusses what is unique about the company and what newsflow investors can expect - Michel Baijot, CEO of Asit Biotech
00:00:00
Avacta Group Plc making 'excellent progress' on lead programmes - Alastair Smith Chief Executive Officer, Avacta Group plc.
00:00:00
Take to the depths of the earth to experience how Bellevue Gold (ASX:BGL) operates - Darren Stralow Managing Director and CEO, Bellevue Gold Ltd
00:00:00
Interview with CEO Jonathan Royce regarding restructuring program -Jonathan Royce Chief Executive Officer, Bio-Works Technologies
00:00:00
Deborah Rathjen, B.Sc. (Hons), Ph.D., MAICD, FTSE Executive Chair, biOasis Technologies Inc
00:00:00
Biomerica seeing their colorectal cancer screening test as a game changer - Zack Irani, CEO, Biomerica Inc
00:00:00
René C. Goehrum | Chairman, President & Chief Executive Officer, Biosyent Inc
00:00:00
How dermatology company is improving the lives of patients suffering from skin diseases- Matt Callahan Executive Director, Botanix Pharmaceuticals Ltd
00:00:00
Developing autologous stem cell therapies for debilitating neurodegenerative diseases - Lebovits, CEO, Brainstorm Cell Therapeutics Inc
00:00:00
Clive Dix BSc PhD HonFBPhS, CEO, C4X Discovery Holdings PLC
00:00:00
Enrolling patients in its coronavirus-induced lung damage treatment study - David Mazzo, CEO, Caladrius Biosciences Inc
00:00:00
Interview with David Reeves, MD - Calidus Resources Ltd
00:00:00
Talk about the partnerships in the success of Project LEILAC and the Calix technology - Phil Hodgson Managing Director & CEO, Calix Ltd
00:00:00
Cambridge Cognition acquires virtual clinical trial firm eClinicalHealth - Dr Matthew Stork Chief Executive Officer, Cambridge Cognition Holdings

© 2017 - Neuhu+